Emmaus Life Sciences Provides Interim Shipment Data

TORRANCE, Calif., April 3, 2023 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle ell disease treatment, announced today preliminary results for the 3 months ended March 31, 2023. “We look forward to reporting our complete interim financial results on our Forms…